Inspection Record

Terumo BCT (Canada) Inc. — Health Canada Inspection Findings

Health CanadaInspected 2026-09-01 7 findingsComplaint and recall handlingLaboratory and QC controlsEquipment and facilityStability and storageDeviation, CAPA, and investigation

View the regulator's official source The source document is always the basis for judgement.

Findings

1Complaint and recall handling

The assessment, recording, follow-up, and/or investigation of complaints and/or other information about potentially defective products was inadequate.

2Laboratory and QC controls

The ongoing stability program for a drug was inadequate. The company did not adequately validate the analytical test procedures used in the stability program.

3Complaint and recall handling

The examination and/or approval of fabrication, packaging, labelling, testing, storage, and/or the transportation method and procedures by the person in charge of the quality control department before implementation was inadequate. The investigation, handling, and/or reporting of test results that were out-of-specification was inadequate. The assessment, recording, follow-up, and/or investigation of complaints and/or other information about potentially defective products was inadequate.

4Laboratory and QC controls

Confirmatory testing was not performed by an alternate laboratory.

5Equipment and facility

The availability, content and/or maintenance of the quality agreements between the supplier, fabricator, tester, packager, labeller, distributor, importer, and/or wholesaler was inadequate.

6Stability and storage

The guidelines and/or procedures were inadequate in ensuring storage and/or transportation conditions would maintain the quality and safe distribution of the drug.

7Deviation, CAPA, and investigation

The investigation, handling, and/or reporting of test results that were out-of-specification was inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2026-09-01. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Terumo BCT (Canada) Inc. findings history — including this company's other documentsAll Health Canada findings Health Canada documents, 2026 Go to Findings search
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.